Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-ethyl-8-methyl-2,8-diazaspiro(4,5)decane-1,3-dione
2. 2-ethyl-8-methyl-2,8-diazaspiro(4,5)decane-1,3-dione Fumarate
3. 2-ethyl-8-methyl-2,8-diazaspiro(4,5)decane-1,3-dione Fumarate (2:1)
4. 2-ethyl-8-methyl-2,8-diazaspiro(4,5)decane-1,3-dione Hydrobromide
5. 2-ethyl-8-methyl-2,8-diazaspiro(4,5)decane-1,3-dione Hydrochloride
6. 2-ethyl-8-methyl-2,8-diazaspiro(4,5)decane-1,3-dione Monofumarate
7. 2-ethyl-8-methyl-2,8-diazaspiro(4,5)decane-1,3-dione Monohydrobromide
8. Rs 86
9. Rs-86
10. Spiro-(n'-methylpiperidyl-4')-n-ethylsuccinimide Fumarate
1. 5asv6m91qu
2. 7524-74-5
3. 2-ethyl-8-methyl-2,8-diazaspiro(4,5)decane-1,3-dione Hydrobromide
4. 2,8-diazaspiro(4.5)decane-1,3-dione, 2-ethyl-8-methyl-, Hydrobromide (1:1)
5. 19105-63-6
6. Chembl542883
7. Unii-5asv6m91qu
8. 2-ethyl-8-methyl-2,8-diazaspiro[4,5]decane-1,3-dione Hydrobromide
9. 2,8-diazaspiro(4,5)decane-1,3-dione, 2-ethyl-8-methyl-, Hydrobromide
10. Dtxsid00940710
11. Q27261758
12. 2-ethyl-8-methyl-2,8-diazaspiro[4.5]decane-1,3-dione--hydrogen Bromide (1/1)
Molecular Weight | 291.18 g/mol |
---|---|
Molecular Formula | C11H19BrN2O2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 1 |
Exact Mass | 290.06299 g/mol |
Monoisotopic Mass | 290.06299 g/mol |
Topological Polar Surface Area | 40.6 Ų |
Heavy Atom Count | 16 |
Formal Charge | 0 |
Complexity | 293 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Parasympathomimetics
Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here. (See all compounds classified as Parasympathomimetics.)
ABOUT THIS PAGE
A Rs-86 Hydrobromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rs-86 Hydrobromide, including repackagers and relabelers. The FDA regulates Rs-86 Hydrobromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rs-86 Hydrobromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Rs-86 Hydrobromide supplier is an individual or a company that provides Rs-86 Hydrobromide active pharmaceutical ingredient (API) or Rs-86 Hydrobromide finished formulations upon request. The Rs-86 Hydrobromide suppliers may include Rs-86 Hydrobromide API manufacturers, exporters, distributors and traders.
click here to find a list of Rs-86 Hydrobromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Rs-86 Hydrobromide DMF (Drug Master File) is a document detailing the whole manufacturing process of Rs-86 Hydrobromide active pharmaceutical ingredient (API) in detail. Different forms of Rs-86 Hydrobromide DMFs exist exist since differing nations have different regulations, such as Rs-86 Hydrobromide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Rs-86 Hydrobromide DMF submitted to regulatory agencies in the US is known as a USDMF. Rs-86 Hydrobromide USDMF includes data on Rs-86 Hydrobromide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Rs-86 Hydrobromide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Rs-86 Hydrobromide suppliers with USDMF on PharmaCompass.
Rs-86 Hydrobromide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Rs-86 Hydrobromide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Rs-86 Hydrobromide GMP manufacturer or Rs-86 Hydrobromide GMP API supplier for your needs.
A Rs-86 Hydrobromide CoA (Certificate of Analysis) is a formal document that attests to Rs-86 Hydrobromide's compliance with Rs-86 Hydrobromide specifications and serves as a tool for batch-level quality control.
Rs-86 Hydrobromide CoA mostly includes findings from lab analyses of a specific batch. For each Rs-86 Hydrobromide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Rs-86 Hydrobromide may be tested according to a variety of international standards, such as European Pharmacopoeia (Rs-86 Hydrobromide EP), Rs-86 Hydrobromide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Rs-86 Hydrobromide USP).
LOOKING FOR A SUPPLIER?